-
EP1909781
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP1909781
| EP1909781 - THERAPEUTIC COMBINATION COMPRISING A NMDA RECEPTORS BLOCKER AND A NARCOTIC ANALGESIC SUBSTANCE [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 31.08.2012 Database last updated on 16.11.2024 | Most recent event Tooltip | 31.08.2012 | Application deemed to be withdrawn | published on 03.10.2012 [2012/40] | Applicant(s) | For all designated states CHIESI FARMACEUTICI S.p.A. Via Palermo, 26/A 43100 Parma / IT | [N/P] |
| Former [2008/16] | For all designated states CHIESI FARMACEUTICI S.p.A. Via Palermo, 26/A I-43100 Parma / IT | Inventor(s) | 01 /
CHIESI, Paolo Via Palermo, 26/A I-43100 Parma / IT | 02 /
VILLETTI, Gino Via Palermo, 26/A I-43100 Parma / IT | [2008/16] | Representative(s) | Minoja, Fabrizio Bianchetti & Minoja S.r.l. Via Plinio, 63 20129 Milano / IT | [N/P] |
| Former [2008/16] | Minoja, Fabrizio Bianchetti Bracco Minoja S.r.l. Via Plinio, 63 20129 Milano / IT | Application number, filing date | 06776280.7 | 18.07.2006 | [2008/16] | WO2006EP07049 | Priority number, date | EP20050016391 | 28.07.2005 Original published format: EP 05016391 | [2008/16] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2007017058 | Date: | 15.02.2007 | Language: | EN | [2007/07] | Type: | A1 Application with search report | No.: | EP1909781 | Date: | 16.04.2008 | Language: | EN | The application published by WIPO in one of the EPO official languages on 15.02.2007 takes the place of the publication of the European patent application. | [2008/16] | Search report(s) | International search report - published on: | EP | 15.02.2007 | Classification | IPC: | A61K31/165, A61K31/135, A61K31/4468, A61K31/485, A61K45/06, A61P25/04, A61P29/00 | [2008/16] | CPC: |
A61K45/06 (EP,US);
A61K31/135 (EP,US);
A61K31/165 (EP,US);
A61K31/4468 (EP,US);
A61K31/485 (EP,US);
A61P25/04 (EP);
| C-Set: |
A61K31/135, A61K2300/00 (EP,US);
A61K31/165, A61K2300/00 (US,EP);
A61K31/4468, A61K2300/00 (US,EP);
A61K31/485, A61K2300/00 (US,EP) | Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR [2008/16] | Extension states | AL | 07.01.2008 | BA | 07.01.2008 | HR | 07.01.2008 | MK | 07.01.2008 | RS | 07.01.2008 | Title | German: | THERAPEUTISCHE KOMBINATION MIT EINEM NMDA-REZEPTORBLOCKER UND NARKOTISCHE ANALGETISCHE SUBSTANZ | [2008/16] | English: | THERAPEUTIC COMBINATION COMPRISING A NMDA RECEPTORS BLOCKER AND A NARCOTIC ANALGESIC SUBSTANCE | [2008/16] | French: | COMBINAISON THÉRAPEUTIQUE COMPRENANT UN BLOQUANT DE RÉCEPTEURS NMDA ET UNE SUBSTANCE ANALGÉSIQUE NARCOTIQUE | [2008/16] | Entry into regional phase | 07.01.2008 | National basic fee paid | 07.01.2008 | Designation fee(s) paid | 07.01.2008 | Examination fee paid | Examination procedure | 07.01.2008 | Examination requested [2008/20] | 17.10.2011 | Despatch of a communication from the examining division (Time limit: M04) | 01.02.2012 | Application deemed to be withdrawn, date of legal effect [2012/40] | 22.03.2012 | Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time [2012/40] | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 17.10.2011 | Fees paid | Renewal fee | 25.07.2008 | Renewal fee patent year 03 | 28.07.2009 | Renewal fee patent year 04 | 26.07.2010 | Renewal fee patent year 05 | Penalty fee | Additional fee for renewal fee | 31.07.2011 | 06 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [YD]WO03053429 (CHIESI FARMA SPA [IT], et al) [YD] 1-14 * the whole document *; | [Y]EP0615749 (UNIV VIRGINIA COMMONWEALTH [US]) [Y] 1-14 * example - *; | [Y] - PARSONS C G, "NMDA RECEPTORS AS TARGETS FOR DRUG ACTION IN NEUROPATHIC PAIN", EUROPEAN JOURNAL OF PHARMACOLOGY, AMSTERDAM, NL, (20011019), vol. 429, no. 1-3, ISSN 0014-2999, pages 71 - 78, XP001076802 [Y] 1-14 * the whole document * DOI: http://dx.doi.org/10.1016/S0014-2999(01)01307-3 | [DY] - VILLETTI, G. ET AL., "Antinociceptive activity of the N-methyl-D-aspartate receptor antagonist N-(2-indanyl)-glycinamide hydrochloride (CHF3381) in experimental models of inflammatory and neuropathic pain", JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, (2003), vol. 306, no. 2, pages 804 - 814, XP002404772 [DY] 1-14 * the whole document * DOI: http://dx.doi.org/10.1124/jpet.103.050039 | [A] - BACKONJA, M.M. ET AL., "The effect of continuous morphine analgesia on chronic thermal hyperalgesia due to sciatic constriction injury in rats", NEUROSCIENCE LETTERS, (1995), vol. 196, pages 61 - 64, XP002404773 [A] 1-14 * the whole document * DOI: http://dx.doi.org/10.1016/0304-3940(95)11844-M |